Multiple sclerosis (MS) is a chronic inflammatory demyelinating central nervous system
disease that typically strikes young adults, especially women. The pathobiology of MS …

Objective To review the current evidence regarding pregnancy-related issues in multiple
sclerosis (MS) and to provide recommendations specific for each of them. Research design …

Pregnancy and multiple sclerosis: an update : Current Opinion in Obstetrics and Gynecology
Pregnancy and multiple sclerosis: an update : Current Opinion in Obstetrics and Gynecology …

Purpose of this Review: This article is a systematic review on the influence pregnancy has
on multiple sclerosis and the resulting impact of disease-modifying therapies. Findings …

Teriflunomide, a once daily, oral disease-modifying therapy, has demonstrated consistent
efficacy, safety and tolerability in patients with relapsing forms of multiple sclerosis (MS) and …

Background: Immunosuppressive drugs have been used in the treatment of multiple
sclerosis (MS) for a long time. Today, orally available second generation …

Background Today, there are no recommendations on switching disease-modifying
treatments (DMTs) in multiple sclerosis (MS). Objectives To establish guidelines on …

Triple-negative breast cancer (TNBC) is defined as a group of primary breast cancers
lacking expression of estrogen, progesterone, and human epidermal growth factor receptor …

Teriflunomide (Aubagio®) is a once-daily oral immunomodulatory disease modifying
therapy (DMT) presently approved in several regions, including Europe, North America …

Therapeutic drug monitoring (TDM) is extremely helpful in individualizing dosage regimen of
drugs with narrow therapeutic ranges. It may also be beneficial in the case of drugs …